Biden expected to pick former FDA Commissioner Dr. Robert Califf to run the agency

  • President Joe Biden is expected to pick Dr. Robert Califf to serve as the head of the Food and Drug Administration, NBC News reported Friday, citing people familiar with the selection process.
  • The FDA, currently overseen by acting Commissioner Dr. Janet Woodcock, has been without a permanent chief since Biden took office in January.
  • Califf, a cardiologist, was briefly the agency's commissioner under the Obama administration beginning in 2016.

President Joe Biden is expected to pick Dr. Robert Califf to serve as the chief of the Food and Drug Administration, NBC News reported Friday, citing people familiar with the selection process.

The FDA, currently overseen by acting Commissioner Dr. Janet Woodcock, has been without a permanent chief since Biden took office in January. The White House reportedly ruled out Woodcock after she faced opposition from some members of Congress over her handling of opioids while at the agency.

Califf, a cardiologist who works at the Duke University School of Medicine, was briefly the agency's commissioner under the Obama administration beginning in 2016. He also served as deputy commissioner of the FDA's medical products and tobacco office.

The new selection is expected imminently because Woodcock cannot legally stay on as the acting head past Nov. 15 without a nominee to hold the position permanently.

Biden's expected nomination comes amid the ongoing Covid-19 pandemic, which has killed at least 759,678 Americans, according to data compiled by Johns Hopkins University.

The FDA has helped bring lifesaving treatments to the market and authorized the use of Covid vaccines, which have shown to be highly effective, especially against severe disease, hospitalization and death.

More than 194 million Americans are fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention.

The FDA has recently come under harsh criticism, though, over its decision to approve Biogen's Alzheimer's drug, Aduhelm.

CNBC Health & Science

Read CNBC's latest global coverage of the Covid pandemic:

UK Covid rates are now falling rapidly despite dire warnings for the winter

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

Virginia pharmacy incorrectly administers Covid vaccine to 112 kids, officials pull remaining doses

Moderna says Covid vaccine has fewer breakthrough cases than Pfizer's, but higher myocarditis rates

Germany's Covid response was praised. Now it has 50,000 cases a day, prompting a dramatic warning

Source: Read Full Article